Arch Venture Fund IX Overage, 10% Owner of Lyell Immunopharma LYEL, has filed 6 purchases and 0 sales on the open market. Over the past 12 months that comes to a net purchase of $12.5M. The latest trade was on 03/06.

AO

AO

Arch Venture Fund IX Overage

10% Owner

Company

Lyell Immunopharma LYEL

First filing

24/02/12

Trades

16 trades

Buys / sales

6 / 0

12-month net buying

$12.5M

Last trade

03/06

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Lyell ImmunopharmaLYEL	Open-market buy	03/06	03/09	488,090 sh	$25.61	$12,499,984.9	+52.0%
Boundless BioBOLD	Open-market buy	24/04/02	24/04/04	200,000 sh2 trades	$16.00avg.	$3,200,000	+20.4%
Sana BiotechnologySANA	Open-market buy	24/02/08	24/02/12	1,818,181 sh3 trades	$5.50avg.	$9,999,995.5	+17.1%